Simplex Trading
EGRX

Simplex Trading’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Simplex Trading’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,100
Closed -$11K – 10087
2024
Q1 		$11K Sell
2,100
-3,900
-65% -$21.4K ﹤0.01% 7576
2023
Q4 		$31K Buy
+6,000
New +$59.2K ﹤0.01% 6553
2020
Q4 		– Sell
-4
Closed -$16K – 9239
2020
Q3 		$16K Sell
4
-77
-95% -$3.37K ﹤0.01% 6529
2020
Q2 		$388K Sell
81
-369
-82% -$18.4K ﹤0.01% 3219
2020
Q1 		$2.07M Buy
450
+80
+22% +$4.01K ﹤0.01% 1254
2019
Q4 		$2.22M Buy
370
+224
+153% +$13.4K ﹤0.01% 1389
2019
Q3 		$825K Sell
146
-109
-43% -$6.13K ﹤0.01% 2126
2019
Q2 		$1.42M Buy
255
+143
+128% +$7.46K ﹤0.01% 1583
2019
Q1 		$565K Sell
112
-211
-65% -$9.39K ﹤0.01% 2530
2018
Q4 		$1.3M Sell
323
-103
-24% -$5.31K ﹤0.01% 1415
2018
Q3 		$2.95M Buy
426
+272
+177% +$20.6K 0.01% 943
2018
Q2 		$1.17M Buy
154
+16
+12% +$1.01K ﹤0.01% 1649
2018
Q1 		$32K Sell
138
-129
-48% -$7.5K ﹤0.01% 2886
2017
Q4 		$71K Buy
267
+93
+53% +$5.18K ﹤0.01% 2111
2017
Q3 		$70K Buy
174
+161
+1,238% +$9.74K ﹤0.01% 2002
2017
Q2 		$2K Sell
13
-6
-32% -$491 ﹤0.01% 5385
2017
Q1 		$8K Sell
19
-137
-88% -$10.2K ﹤0.01% 4213
2016
Q4 		$53K Buy
156
+78
+100% +$5.67K ﹤0.01% 2103
2016
Q3 		$3K Sell
78
-212
-73% -$11.7K ﹤0.01% 4759
2016
Q2 		$49K Buy
290
+261
+900% +$10.9K ﹤0.01% 2084
2016
Q1 		$25K Sell
29
-16
-36% -$1.01K ﹤0.01% 2608
2015
Q4 		$45K Sell
45
-4
-8% -$316 ﹤0.01% 2006
2015
Q3 		$62K Sell
49
-31
-39% -$2.58K ﹤0.01% 1821
2015
Q2 		$31K Buy
+80
New +$5.21K ﹤0.01% 2077

Other funds holding EGRX

SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
AIC
Archer Investment Corporation Carmel, Indiana $469M AUM 19.1% 1-Year Est. Return

Simplex Trading's EGRX Position: Q1 2025 in Review

Simplex Trading sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2025, closing a stake of 18,162 shares — an estimated $9K sold.

Simplex Trading first reported a position in EGRX in Q2 2015 and held it in 16 quarters. The position peaked at $1.02M in Q1 2020. 2 funds tracked by Wall St. Rank hold EGRX as of Q1 2025.

  • Simplex Trading reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 18,162 Eagle Pharmaceuticals, Inc. shares in Q1 2025, an estimated $9K.
  • Simplex Trading first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2015 and held it in 16 quarters.
  • Simplex Trading's Eagle Pharmaceuticals, Inc. position peaked at $1.02M in Q1 2020.
  • 2 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.